Goldman Sachs’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.64M | Sell |
114,331
-5,598
| -5% | -$227K | ﹤0.01% | 2861 |
|
|
2025
Q1 | $5.25M | Buy |
119,929
+59,007
| +97% | +$2.58M | ﹤0.01% | 2705 |
|
|
2024
Q4 | $2.62M | Buy |
60,922
+6,316
| +12% | +$272K | ﹤0.01% | 3304 |
|
|
2024
Q3 | $2.42M | Buy |
54,606
+14,552
| +36% | +$646K | ﹤0.01% | 3237 |
|
|
2024
Q2 | $1.59M | Sell |
40,054
-115,684
| -74% | -$4.6M | ﹤0.01% | 3319 |
|
|
2024
Q1 | $6.72M | Buy |
155,738
+55,738
| +56% | +$2.4M | ﹤0.01% | 2349 |
|
|
2023
Q4 | $4.16M | Sell |
100,000
-77,043
| -44% | -$3.21M | ﹤0.01% | 2728 |
|
|
2023
Q3 | $7.04M | Sell |
177,043
-6,115
| -3% | -$243K | ﹤0.01% | 2228 |
|
|
2023
Q2 | $7.51M | Sell |
183,158
-133,979
| -42% | -$5.49M | ﹤0.01% | 2263 |
|
|
2023
Q1 | $13M | Buy |
317,137
+50,437
| +19% | +$2.07M | ﹤0.01% | 1816 |
|
|
2022
Q4 | $10.9M | Buy |
266,700
+130,565
| +96% | +$5.35M | ﹤0.01% | 2066 |
|
|
2022
Q3 | $5.47M | Buy |
136,135
+83,941
| +161% | +$3.37M | ﹤0.01% | 2574 |
|
|
2022
Q2 | $2.19M | Sell |
52,194
-455,723
| -90% | -$19.1M | ﹤0.01% | 3368 |
|
|
2022
Q1 | $23M | Sell |
507,917
-69,261
| -12% | -$3.14M | ﹤0.01% | 1632 |
|
|
2021
Q4 | $26.6M | Sell |
577,178
-49,280
| -8% | -$2.27M | 0.01% | 1561 |
|
|
2021
Q3 | $29.7M | Buy |
626,458
+180,825
| +41% | +$8.58M | 0.01% | 1439 |
|
|
2021
Q2 | $23.1M | Sell |
445,633
-207,140
| -32% | -$10.7M | 0.01% | 1632 |
|
|
2021
Q1 | $32.9M | Buy |
652,773
+28,112
| +5% | +$1.42M | 0.01% | 1315 |
|
|
2020
Q4 | $32.5M | Buy |
624,661
+119,789
| +24% | +$6.24M | 0.01% | 1239 |
|
|
2020
Q3 | $22M | Sell |
504,872
-97,112
| -16% | -$4.22M | 0.01% | 1418 |
|
|
2020
Q2 | $25.9M | Sell |
601,984
-15,732
| -3% | -$676K | 0.01% | 1297 |
|
|
2020
Q1 | $22.3M | Sell |
617,716
-246,353
| -29% | -$8.89M | 0.01% | 1258 |
|
|
2019
Q4 | $39.5M | Buy |
864,069
+9,596
| +1% | +$438K | 0.01% | 1177 |
|
|
2019
Q3 | $30.4M | Buy |
854,473
+172,797
| +25% | +$6.15M | 0.01% | 1274 |
|
|
2019
Q2 | $27.2M | Sell |
681,676
-25,580
| -4% | -$1.02M | 0.01% | 1397 |
|
|
2019
Q1 | $29.4M | Sell |
707,256
-65,786
| -9% | -$2.74M | 0.01% | 1349 |
|
|
2018
Q4 | $28.3M | Buy |
773,042
+306,918
| +66% | +$11.2M | 0.01% | 1317 |
|
|
2018
Q3 | $22.6M | Sell |
466,124
-48,100
| -9% | -$2.34M | 0.01% | 1572 |
|
|
2018
Q2 | $22.1M | Sell |
514,224
-1,730
| -0.3% | -$74.4K | 0.01% | 1565 |
|
|
2018
Q1 | $21.6M | Buy |
515,954
+637
| +0.1% | +$26.7K | 0.01% | 1533 |
|
|
2017
Q4 | $22.4M | Sell |
515,317
-410,359
| -44% | -$17.8M | 0.01% | 1500 |
|
|
2017
Q3 | $39.4M | Buy |
925,676
+17,328
| +2% | +$737K | 0.01% | 1195 |
|
|
2017
Q2 | $39.1M | Buy |
908,348
+122,374
| +16% | +$5.27M | 0.01% | 1166 |
|
|
2017
Q1 | $32.9M | Buy |
785,974
+268,882
| +52% | +$11.2M | 0.01% | 1252 |
|
|
2016
Q4 | $20.2M | Sell |
517,092
-211,517
| -29% | -$8.27M | 0.01% | 1477 |
|
|
2016
Q3 | $32.2M | Buy |
728,609
+109,994
| +18% | +$4.86M | 0.01% | 1218 |
|
|
2016
Q2 | $25.9M | Sell |
618,615
-1,957,882
| -76% | -$81.8M | 0.01% | 1261 |
|
|
2016
Q1 | $104M | Buy |
2,576,497
+1,456,640
| +130% | +$58.6M | 0.03% | 549 |
|
|
2015
Q4 | $57.3M | Buy |
1,119,857
+505,478
| +82% | +$25.9M | 0.02% | 810 |
|
|
2015
Q3 | $28.8M | Buy |
614,379
+134,869
| +28% | +$6.33M | 0.01% | 1100 |
|
|
2015
Q2 | $29.9M | Buy |
479,510
+471,394
| +5,808% | +$29.4M | 0.01% | 1149 |
|
|
2015
Q1 | $501K | Sell |
8,116
-300,722
| -97% | -$18.6M | ﹤0.01% | 3312 |
|
|
2014
Q4 | $16.7M | Buy |
308,838
+116
| +0% | +$6.26K | 0.01% | 1370 |
|
|
2014
Q3 | $16.4M | Sell |
308,722
-694,372
| -69% | -$36.8M | 0.01% | 1357 |
|
|
2014
Q2 | $52.1M | Buy |
1,003,094
+641,286
| +177% | +$33.3M | 0.02% | 795 |
|
|
2014
Q1 | $16.9M | Buy |
361,808
+337,268
| +1,374% | +$15.8M | 0.01% | 1319 |
|
|
2013
Q4 | $1.08M | Buy |
24,540
+6,942
| +39% | +$305K | ﹤0.01% | 3023 |
|
|
2013
Q3 | $677K | Buy |
+17,598
| New | +$677K | ﹤0.01% | 3150 |
|